{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:10:01Z","timestamp":1751544601722,"version":"3.41.0"},"reference-count":31,"publisher":"American Veterinary Medical Association (AVMA)","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec id=\"sc_a1\">\n<jats:title>Objective<\/jats:title>\n<jats:p>To evaluate the RNA and protein expression of hypoxia-inducible factor (HIF-1\u03b1) in canine urothelial carcinoma (UC) compared to normal canine urinary bladder tissue.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sc_a2\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Dogs with normal urinary bladder tissue were enrolled at the time of euthanasia with the tissue obtained via necropsy within 1 hour after death. The high-grade UC tissue was collected via necropsy or cystoscopically utilizing a resectoscope. Dogs in the UC group were excluded if they were treated with chemotherapy or radiation therapy prior to tissue collection. Immunohistochemistry was performed on all tissues to evaluate intracytoplasmic and intranuclear immunoreactivity of HIF-1\u03b1 using a semiquantitative immunoreactivity score (IRS). Ribonucleic acid sequencing was also performed to evaluate the expression of HIF-1\u03b1 in normal urinary bladders and canine UC.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sc_a3\">\n<jats:title>Results<\/jats:title>\n<jats:p>10 dogs with high-grade UC and 10 dogs with normal urinary bladder tissue were enrolled. The median intracytoplasmic HIF-1\u03b1 in the UC group was mild in intensity with a low percentage of positive cells (median IRS, 1; range, 0 to 2). The control dogs had similar intracytoplasmic HIF-1\u03b1 expression (median IRS, 1; range, 0 to 1). The difference in RNA expression of HIF-1\u03b1 between groups was not significant (1.3-fold change).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sc_a4\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study did not identify any differential RNA or protein expression of HIF-1\u03b1 between normal urinary bladder tissue and UC in dogs.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sc_a5\">\n<jats:title>Clinical Relevance<\/jats:title>\n<jats:p>HIF-1\u03b1 is not differentially expressed in canine UC, but further exploration is necessary to evaluate if other proteins associated with hypoxia and angiogenesis could play a role in tumor growth and chemotherapy resistance in canine UC.<\/jats:p>\n<\/jats:sec>","DOI":"10.2460\/ajvr.24.12.0391","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T13:35:16Z","timestamp":1745847316000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia-inducible factor 1\u03b1 expression does not differ between canine urothelial carcinoma and normal urinary bladder tissue"],"prefix":"10.2460","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-9366","authenticated-orcid":true,"given":"Nicole H.","family":"Gibbs","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario F.","family":"Sola","sequence":"additional","affiliation":[{"name":"Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Dhawan","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Knapp","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Foster","sequence":"additional","affiliation":[{"name":"Friendship Hospital for Animals, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Kendall","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Woolcock","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"B1","series-title":"Small Animal Clinical Oncology","first-page":"645","article-title":"Tumors of the urinary system","author":"Knapp DW","year":"2019","unstructured":"Knapp DW, McMillan SK. Tumors of the urinary system. In: Withrow SJ, Vail DM, eds. Small Animal Clinical Oncology. 6th ed. Elsevier-Saunders; 2019:645\u2013656."},{"key":"B2","series-title":"Front Oncol","first-page":"1493","article-title":"Naturally-occurring invasive urothelial carcinoma in dogs, a unique model to drive advances in managing muscle invasive bladder cancer in humans","volume":"9","author":"Knapp DW","year":"2020","unstructured":"Knapp DW, Dhawan D, Ramos-Vara JA, et al. Naturally-occurring invasive urothelial carcinoma in dogs, a unique model to drive advances in managing muscle invasive bladder cancer in humans. Front Oncol. 2020;9:1493. doi:10.3389\/fonc.2019.01493"},{"issue":"2","key":"B3","series-title":"J Vet Intern Med","first-page":"1052","article-title":"Treatment of genitourinary carcinoma in dogs using nonsteroidal anti-inflammatory drugs, mitoxantrone, and radiation therapy: a retrospective study","volume":"35","author":"Clerc-Renaud B","year":"2021","unstructured":"Clerc-Renaud B, Gieger TL, LaRue SM, Nolan MW. Treatment of genitourinary carcinoma in dogs using nonsteroidal anti-inflammatory drugs, mitoxantrone, and radiation therapy: a retrospective study. J Vet Intern Med. 2021;35(2):1052\u20131061. doi:10.1111\/jvim.16078"},{"key":"B4","series-title":"Annu Rev Physiol","first-page":"103","article-title":"The acidic tumor microenvironment as a driver of cancer","volume":"82","author":"Boedtkjer E","year":"2020","unstructured":"Boedtkjer E, Pedersen SF. The acidic tumor microenvironment as a driver of cancer. Annu Rev Physiol. 2020;82:103\u2013126. doi:10.1146\/annurev-physiol-021119-034627"},{"key":"B5","series-title":"Hypoxia (Auckl)","first-page":"83","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz B","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015;3:83\u201392. doi:10.2147\/HP.S93413"},{"issue":"7","key":"B6","series-title":"Clin Cancer Res","first-page":"2583","article-title":"Expression of hypoxia-inducible factor-1\u03b1 protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract","volume":"11","author":"Nakanishi K","year":"2005","unstructured":"Nakanishi K, Hiroi S, Tominaga S, et al. Expression of hypoxia-inducible factor-1\u03b1 protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Clin Cancer Res. 2005;11(7):2583\u20132590. doi:10.1158\/1078-0432.CCR-04-1685"},{"issue":"4","key":"B7","series-title":"Oncol Rep","first-page":"909","article-title":"Expression of HIF-1\u03b1 and glut-1 in human bladder cancer","volume":"14","author":"Palit V","year":"2005","unstructured":"Palit V, Phillips RM, Puri R, Shah T, Bibby MC. Expression of HIF-1\u03b1 and glut-1 in human bladder cancer. Oncol Rep. 2005;14(4):909\u2013913. doi:10.3892\/or.14.4.909"},{"issue":"2","key":"B8","series-title":"Eur Urol","first-page":"200","article-title":"Hypoxia-inducible factor 1\u03b1 expression correlates with angiogenesis and unfavorable prognosis in bladder cancer","volume":"46","author":"Theodoropoulos VE","year":"2004","unstructured":"Theodoropoulos VE, Lazaris AC, Sofras F, et al. Hypoxia-inducible factor 1\u03b1 expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol. 2004;46(2):200\u2013208. doi:10.1016\/j.eururo.2004.04.008"},{"issue":"3","key":"B9","series-title":"BJU Int","first-page":"425","article-title":"Evaluation of hypoxia-inducible factor 1\u03b1 overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma","volume":"95","author":"Theodoropoulos VE","year":"2005","unstructured":"Theodoropoulos VE, Lazaris AC, Kastriotis I, et al. Evaluation of hypoxia-inducible factor 1\u03b1 overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. BJU Int. 2005;95(3):425\u2013431. doi:10.1111\/j.1464-410X.2005.05314.x"},{"issue":"1","key":"B10","series-title":"Int Urol Nephrol","first-page":"103","article-title":"Evaluation of relationship between HIF-1\u03b1 immunoreactivity and stage, grade, angiogenic profile and proliferative index in bladder urothelial carcinomas","volume":"42","author":"Deniz H","year":"2010","unstructured":"Deniz H, Karak\u00f6k M, Yagci F, G\u00fcld\u00fcr ME. Evaluation of relationship between HIF-1\u03b1 immunoreactivity and stage, grade, angiogenic profile and proliferative index in bladder urothelial carcinomas. Int Urol Nephrol. 2010;42(1):103\u2013107. doi:10.1007\/s11255-009-9590-5"},{"issue":"5","key":"B11","series-title":"J Clin Pathol","first-page":"658","article-title":"Hypoxia-inducible factor-1\u03b1 expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma","volume":"61","author":"Chai CY","year":"2008","unstructured":"Chai CY, Chen WT, Hung EC, et al. Hypoxia-inducible factor-1\u03b1 expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol. 2008;61(5):658\u2013664. doi:10.1136\/jcp.2007.050666"},{"issue":"1","key":"B12","series-title":"Int J Oncol","first-page":"215","article-title":"Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1\u03b1 activation","volume":"53","author":"Yang X","year":"2018","unstructured":"Yang X, Yin H, Zhang Y, et al. Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1\u03b1 activation. Int J Oncol. 2018;53(1):215\u2013224. doi:10.3892\/ijo.2018.4376"},{"issue":"2","key":"B13","series-title":"Arch Ital Urol Androl","first-page":"11292","article-title":"The association between serum hypoxia inducible factor-1\u03b1 level and urothelial bladder cancer: a preliminary study","volume":"95","author":"Siregar GP","year":"2023","unstructured":"Siregar GP, Parwati I, Noegroho BS, et al. The association between serum hypoxia inducible factor-1\u03b1 level and urothelial bladder cancer: a preliminary study. Arch Ital Urol Androl. 2023;95(2):11292. doi:10.4081\/aiua.2023.11292"},{"issue":"4","key":"B14","series-title":"Pol J Pathol","first-page":"395","article-title":"HIF-1\u03b1 expression is inversely associated with tumor stage, grade and microvessel density in urothelial bladder carcinoma","volume":"69","author":"Fus \u0141","year":"2018","unstructured":"Fus \u0141, Pihowicz P, Koperski \u0141, Marczewska J, G\u00f3rnicka B. HIF-1\u03b1 expression is inversely associated with tumor stage, grade and microvessel density in urothelial bladder carcinoma. Pol J Pathol. 2018;69(4):395\u2013404. doi:10.5114\/pjp.2018.81699"},{"issue":"1","key":"B15","series-title":"Acta Vet Scand","first-page":"73","article-title":"Expression of hypoxia-inducible factor-1\u03b1 and vascular density in mammary adenomas and adenocarcinomas in bitches","volume":"55","author":"Madej JA","year":"2013","unstructured":"Madej JA, Madej JP, Dziegiel P, Pula B, Nowak M. Expression of hypoxia-inducible factor-1\u03b1 and vascular density in mammary adenomas and adenocarcinomas in bitches. Acta Vet Scand. 2013;55(1):73. doi:10.1186\/1751-0147-55-73"},{"issue":"2\u20133","key":"B16","series-title":"J Comp Pathol","first-page":"101","article-title":"Analysis of hypoxia-inducible factor-1\u03b1 expression relative to other key factors in malignant canine mammary tumours","volume":"153","author":"Shin JI","year":"2015","unstructured":"Shin JI, Lim HY, Kim HW, Seung BJ, Sur JH. Analysis of hypoxia-inducible factor-1\u03b1 expression relative to other key factors in malignant canine mammary tumours. J Comp Pathol. 2015;153(2\u20133):101\u2013110. doi:10.1016\/j.jcpa.2015.05.004"},{"key":"B17","series-title":"Vet J","first-page":"105538","article-title":"Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1\u03b1 and downstream genes in canine appendicular osteosarcoma","volume":"264","author":"Gola C","year":"2020","unstructured":"Gola C, Iussich S, Noury S, et al. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1\u03b1 and downstream genes in canine appendicular osteosarcoma. Vet J. 2020;264:105538. doi:10.1016\/j.tvjl.2020.105538"},{"issue":"11","key":"B18","series-title":"J Vet Med Sci","first-page":"1405","article-title":"Hypoxia inducible factor 1\u03b1 expression and effects of its inhibitors in canine lymphoma","volume":"77","author":"Kambayashi S","year":"2015","unstructured":"Kambayashi S, Igase M, Kobayashi K, et al. Hypoxia inducible factor 1\u03b1 expression and effects of its inhibitors in canine lymphoma. J Vet Med Sci. 2015;77(11):1405\u20131412. doi:10.1292\/jvms.15-0258"},{"issue":"9","key":"B19","series-title":"Int J Urol","first-page":"616","article-title":"Immuno\u00adhistochemical biomarkers for bladder cancer prognosis","volume":"18","author":"Matsushita K","year":"2011","unstructured":"Matsushita K, Cha EK, Matsumoto K, et al. Immuno\u00adhistochemical biomarkers for bladder cancer prognosis. Int J Urol. 2011;18(9):616\u2013629. doi:10.1111\/j.1442-2042.2011.02809.x"},{"issue":"2","key":"B20","series-title":"Vet J","first-page":"217","article-title":"Management of transitional cell carcinoma of the urinary bladder in dogs: a review","volume":"205","author":"Fulkerson CM","year":"2015","unstructured":"Fulkerson CM, Knapp DW. Management of transitional cell carcinoma of the urinary bladder in dogs: a review. Vet J. 2015;205(2):217\u2013225. doi:10.1016\/j.tvjl.2015.01.017"},{"issue":"1","key":"B21","series-title":"Vet Radiol Ultrasound","first-page":"79","article-title":"Ultrasonographic findings related to prognosis in canine transitional cell carcinoma","volume":"55","author":"Hanazono K","year":"2013","unstructured":"Hanazono K, Fukumoto S, Endo Y, Ueno H, Kadosawa T, Uchide T. Ultrasonographic findings related to prognosis in canine transitional cell carcinoma. Vet Radiol Ultrasound. 2013;55(1):79\u201384. doi:10.1111\/vru.12085"},{"issue":"2","key":"B22","series-title":"Oncol Lett","first-page":"1641","article-title":"The dog as an animal model for bladder and urethral urothelial carcinoma: comparative epidemiology and histology","volume":"16","author":"de Brot S","year":"2018","unstructured":"de Brot S, Robinson BD, Scase T, et al. The dog as an animal model for bladder and urethral urothelial carcinoma: comparative epidemiology and histology. Oncol Lett. 2018;16(2):1641\u20131649. doi:10.3892\/ol.2018.8837"},{"issue":"1","key":"B23","series-title":"ILAR J","first-page":"100","article-title":"Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development","volume":"55","author":"Knapp DW","year":"2014","unstructured":"Knapp DW, Ramos-Vara JA, Moore GE, Dhawan D, Bonney PL, Young KE. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. ILAR J. 2014;55(1):100\u2013118. doi:10.1093\/ilar\/ilu018"},{"issue":"2","key":"B24","series-title":"FASEB J","first-page":"264","article-title":"von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis","volume":"16","author":"Jones MK","year":"2002","unstructured":"Jones MK, Szab\u00f3 IL, Kawanaka H, Husain SS, Tarnawski AS. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J. 2002;16(2):264\u2013266. doi:10.1096\/fj.01-0589fje"},{"issue":"10","key":"B25","series-title":"J Mol Med","first-page":"627","article-title":"Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications","volume":"81","author":"Tarnawski AS","year":"2003","unstructured":"Tarnawski AS, Jones MK. Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med. 2003;81(10):627\u2013636. doi:10.1007\/s00109-003-0479-y"},{"issue":"3","key":"B26","series-title":"Int J Mol Sci","first-page":"1432","article-title":"NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase","volume":"23","author":"Kolawole OR","year":"2022","unstructured":"Kolawole OR, Kashfi K. NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase. Int J Mol Sci. 2022;23(3):1432. doi:10.3390\/ijms23031432"},{"key":"B27","series-title":"Onco Targets Ther","first-page":"1727","article-title":"Biological function of HYOU1 in tumors and other diseases","volume":"14","author":"Rao S","year":"2021","unstructured":"Rao S, Oyang L, Liang J, et al. Biological function of HYOU1 in tumors and other diseases. Onco Targets Ther. 2021;14:1727\u20131735. doi:10.2147\/OTT.S297332"},{"issue":"4","key":"B28","series-title":"BJU Int","first-page":"462","article-title":"Immuno\u00adhistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer","volume":"90","author":"Asahi H","year":"2002","unstructured":"Asahi H, Koshida K, Hori O, Ogawa S, Namiki M. Immuno\u00adhistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer. BJU Int. 2002;90(4):462\u2013466. doi:10.1046\/j.1464-410X.2002.02915.x"},{"issue":"12","key":"B29","series-title":"Cancer Sci","first-page":"4037","article-title":"The emerging multifaceted role of PINK1 in cancer biology","volume":"113","author":"Wang M","year":"2022","unstructured":"Wang M, Luan S, Fan X, et al. The emerging multifaceted role of PINK1 in cancer biology. Cancer Sci. 2022;113(12):4037\u20134047. doi:10.1111\/cas.15568"},{"key":"B30","series-title":"Ecotoxicol Environ Saf","first-page":"112420","article-title":"Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagy","volume":"221","author":"Lou Y","year":"2021","unstructured":"Lou Y, Ma C, Liu Z, et al. Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagy. Ecotoxicol Environ Saf. 2021;221:112420. doi:10.1016\/j.ecoenv.2021.112420"},{"issue":"5","key":"B31","series-title":"J Urol","first-page":"1744","article-title":"Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers","volume":"183","author":"Shariat SF","year":"2010","unstructured":"Shariat SF, Youssef RF, Gupta A, et al. Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers. J Urol. 2010;183(5):1744\u20131750. doi:10.1016\/j.juro.2010.01.018"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/86\/7\/ajvr.24.12.0391.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/86\/7\/ajvr.24.12.0391.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/86\/7\/ajvr.24.12.0391.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:00:32Z","timestamp":1751461232000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/86\/7\/ajvr.24.12.0391.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":31,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.24.12.0391","relation":{},"ISSN":["0002-9645","1943-5681"],"issn-type":[{"type":"print","value":"0002-9645"},{"type":"electronic","value":"1943-5681"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}